ArticleHepatology international2023

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma.

Mathew Vithayathil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.